Europe and MENA Wound Care Market – By Product, By Application, By Mode of Purchase, By End Use & Forecast, 2024 – 2032

Europe and MENA Wound Care Market Size

The Europe and MENA wound care market size was valued at around USD 7.5 billion in 2023 and is estimated to grow at 6% CAGR from 2024 to 2032. Wound care is defined as a medical treatment concerned with the management of wounds that results from trauma, surgery, chronic diseases, or other conditions. The main objective of wound care is to facilitate healing, prevent infection, and lessen scarring. Treating wounds usually involves various techniques, procedures and products which are influenced by injury type, dimensions, and severity of the wound.
 

The surging prevalence of complicated wounds, for instance, diabetic foot ulcers and pressure ulcers, is fueling the growth of market. According to the European Wound Management Association (EWMA), nearly four million people have been affected with chronic wounds in a year in the region, which makes the need for effective treatment critical. These solutions are essential for healing and preventing infection while dealing with any acute or chronic wounds.
 

Moreover, innovative technologies such as bioactive dressings and negative pressure wound therapy are propelling the demand by improving treatment results and comfort. Likewise, in the Middle East, there is an increasing use of advanced wound care products resulting from the rising burden of chronic diseases and investment in new healthcare facilities and services. These regions are, however, undergoing faster market growth for wound care products owing to multifactorial reasons such as the large patient population and technological growth, as well as improving access to healthcare.
 

Europe and MENA Wound Care Market Trends

•      Diabetes, obesity, and vascular diseases are more common across Europe nowadays which means chronic wounds such as diabetic foot ulcers and pressure ulcers are on the rise. This drives the need for comprehensive and advanced solutions, encompassing dressings, skin substitutes and even negative pressure wound therapy NPWT.
   
•  With the advancements in wound care products, the treatment possibilities are also increasing. These include bioactive and antimicrobial dressings, and growth factor infused therapies. Digital technologies, including AI, are being put to practical use in monitoring wound healing progress and as a result, the whole of Europe is embracing them.
   
•    Middle East North Africa (MENA) governments have invested in the enhancement of the general healthcare systems improving the access to modern approach treatment for chronic conditions. The increased availability of products and utilization of these advanced products in hospitals and clinics have been resulted from these investments.
   

Europe and MENA Wound Care Market Analysis

Based on product, the market is segmented into advanced wound dressings, surgical wound care, traditional wound care, wound therapy devices, and wound care biologics. The advanced wound dressings segment dominated the market with the largest revenue of USD 2.4 billion in 2023.
 

• The healing process is greatly advanced using advanced wound dressing with bioactive materials and negative pressure systems. They facilitate the body to defend and heal the wound by creating optimal conditions for repair. Compared to traditional dressings, they encourage faster epithelialization and collagen formation.
   
• A study done by the National Institute of Health (NIH) demonstrates the benefits of negative pressure wound therapy (NPWT) in advanced wound care. NPWT shows great results for acute and chronic wounds by granulating tissue and lessening the infection risks.
   
• Several advanced dressings also make use of anti-infectives or silver nanoparticles to reduce the risk of infection, which is quite useful in chronic or high-risk wounds.
   
• These factors collectively drive the substantial growth of the market, making advanced wound dressings a vital component of modern healthcare solutions.
   

Based on application, the Europe and MENA wound care market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment is further sub-segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. In addition, the acute wounds segment is further bifurcated into surgical wounds, traumatic wounds, and burns. The acute wounds segment dominated the market and was valued at USD 4.2 billion in 2023.
 

• Acute wounds are the most common injuries incurred in trauma or surgery. In particular, they cover a wide range of surgical incisions, lacerations, and abrasions that are expected to heal over the course of a few weeks if given proper care and management.
   
• The proper management of acute wounds involves wound cleansing, adequate coverage of the wound with dressing to avoid infection, and inspection for signs of infection.
   
• Increased spending for healthcare, accompanied by better understanding of the importance of caring for wounds, promotes the use of advanced wound care techniques.
  
   
• Such favorable conditions, along with the increasing tendency of outpatient treatment and reduced period of hospitalization, has led to a greater market for wound care products which enable faster healing at home.
   
• Collectively, these factors have significantly contributed to the growth of the acute wound care segment in the EMENA market.
   

Based on mode of purchase, the Europe and MENA wound care market is bifurcated into prescribed and non-prescribed. The prescribed segment held the largest revenue of USD 5.4 billion in 2023.
 

• A combination of growing aging population, increasing rates of diabetes, and obesity is sited as factors for the increased incidence of chronic wounds. As a result, there is a greater need for prescribed advanced wound care solutions. These include dressings, antimicrobial agents, and negative pressure wound therapy (NPWT) which are recommended by the physician.
   
• These prescribed types of treatments are very important for the management of chronic wounds like diabetic ulcers, pressure sores, and venous leg ulcers which are a burden to millions of people around the globe.
   
• The physicians usually prescribe advanced dressing bandages and ointments with the aim of enhancing tissue regeneration. They are designed to control infections as well as smearing dressings that ensure the wound remains moist. Consequently, cell proliferation is promoted and the likelihood of infections along with chronic wounds is diminished.
   

Based on end use, the Europe and MENA wound care market is segmented into hospitals, specialty clinics, home care settings, and other end users. The hospitals segment held the largest revenue of USD 3 billion in 2023.
 

• The rising incidence of chronic wounds such as diabetic foot ulcers and pressure sores among the elderly population has greatly increased the need for sophisticated wound care within hospitals.
   
• In addition, hospitals are now equipping themselves with advanced technologies and new devices to ensure better patient care and to address and prevent complications arising from wounds. The increased focus on infection prevention as well as the general need for surgical wound care in hospitals further drive this growth.
   
• Moreover, the development of health infrastructure and the spending on hospital-based wound care services within EMENA is strengthening market growth.
   
• Therefore, as hospitals continue to prioritize advanced wound care treatments and technologies, this segment is poised to experience substantial growth over the forecast period.
   

The Europe and MENA wound care market is forecasted to reach USD 12.7 billion by 2032. Europe dominated the market with the largest revenue of USD 6.9 billion in 2023.
 

• The greater occurrence of chronic conditions like diabetes and cardiovascular diseases in Europe significantly enhances the need for wounds care products. As per European Society of Cardiology declared, cardiovascular disease is responsible for 3.9 million deaths in Europe every year, more over 1.8 million in European Union.
   
• In Europe, CVD accounts for 45% of all deaths while in the EU, accounts for 37%, It remains the leading cause of death for men in all but 12 European countries, and the primary cause of mortality for those under 65 years of age.
   
• Due to this, the chronic diseases often result in complex wounds, including diabetic foot ulcers and certain surgical wounds, that need advanced wound care.
   

The market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• A notable factor propelling the growth of the wound care market in this country is the aging population which is more susceptible to chronic wounds like pressure ulcers, venous leg ulcers as well as diabetic foot ulcers. As more elderly people tend to suffer from reduced mobility, diabetes, and poor circulation to the legs, the demand for sophisticated advanced wound care also increases.
   
• Moreover, NHS the biggest healthcare system in UK is keen on cutting costs and improving the quality of care. There is an increased focus on putting less burden on hospitals and enhancing outpatient as well as community-based wound care. This approach has supported the use of home care wound healing therapies and advanced dressings to reduce hospital stays.
   

The Europe and MENA wound care market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

• Patients suffering from diabetic foot ulcers or other chronic wounds are quite common in Saudi Arabia as they have some of the highest diabetes incidences.
   
• It was reported that 17.7% of Saudi Arabian were diabetic in the year 2021 in the International Diabetes Federation report.
   
• There is an increase in chronic wounds like venous leg ulcers and pressure ulcers due to increasing obesity along with cardiovascular disease rates in Saudi Arabia. This adds to the rising need for advanced wound care therapies aimed at minimizing problems such as infection and amputation.
   

Europe and MENA Wound Care Market Share

The market, incorporating mergers and acquisitions activities, is multi-faceted and dynamic owing to modern technology and market competition. Top five leading players such as Convatec Group PLC, Essity AB, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and 3M Company, are changing the market dynamics with advanced wound care and additional product lines, and collaboration.
 

The market is positively impacted by trends such as the development of advanced wound dressings, expanding to new regions, and efforts to navigate complex regulatory environments. While challenges such as excessive cost of development costs and stringent regulatory landscape, there are substantial opportunities in the market for advanced tissue engineering, personalized medicines, and economical bioprinting techniques. Companies optimally utilize these gaps in the market, along with the hurdles presented to the market, will prove to be quite resourceful in the Europe and MENA regions for wound care.
 

Europe and MENA Wound Care Market Companies

Some of the eminent market participants operating in the Europe and MENA wound care industry include:

• Advancis Medical
• B. Braun Melsungen
• Baxter International
• Coloplast
• Convatec Group
• Essity
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Medline Industries
• Medtronic
• Mölnlycke Health Care
• Smith & Nephew
• URGO Medical
• 3M Company
   
• Medtronic is focusing on developing advanced antimicrobial dressings with enhanced infection control properties.
   
• Smith & Nephew is expanding their product portfolios through strategic acquisitions and partnerships.
   
• Johnson & Johnson is developing cost-effective solutions for emerging markets.
   

Europe and MENA Wound Care Industry News: 

• In July 2024, Mölnlycke Health Care AB, a leading global MedTech company specializing in solutions for wound care and surgical procedures, announced an investment of USD 15 million in MediWound Ltd., through a definitive share purchase agreement as part of a private investment in public equity (PIPE). This investment in MediWound, Ltd. enhanced Mölnlycke Health Care AB's portfolio of innovative wound care solutions.
   
• In January 2022, Convatec Group PLC, announced the acquisition of Triad Life Sciences Inc., a US-based medical device company that developed biologically derived innovative products aimed at addressing unmet clinical needs in surgical wounds, chronic wounds, and burns. This acquisition enhanced Convatec’s product portfolio and strengthen its position in the EMENA wound care market.
   

The Europe and MENA wound care market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Advanced wound dressings
  • Foam dressings
  • Hydrocolloid dressings
  • Film dressings
  • Alginate dressings
  • Hydrogel dressings
  • Collagen dressings
  • Other advanced dressings
• Surgical wound care
  • Sutures and staplers
  • Tissue adhesives and sealants
  • Anti-infective dressings
• Traditional wound care
  • Medical tapes
  • Cotton
  • Bandages
  • Gauzes
  • Sponges
  • Cleansing agents
• Wound therapy devices
  • Negative pressure wound therapy
  • Oxygen and hyperbaric oxygen equipment
  • Electric stimulation devices
  • Pressure relief devices
  • Other wound therapy devices
• Wound care biologics
  • Skin substitutes
    • Biological
      • Allograft
      • Xenograft
      • Other biologicals
    • Synthetic
  • Topical agents

Market, By Application

• Chronic wounds
  • Diabetic foot ulcers
  • Pressure ulcers
  • Venous leg ulcers
  • Other chronic wounds
• Acute wounds
  • Surgical wounds
  • Traumatic wounds
  • Burns

Market, By Mode of Purchase

• Prescribed
• Non-prescribed

Market, By End Use

• Hospitals
• Specialty clinics
• Home care settings
• Other end users

The above information is provided for the following regions and countries:

• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Ukraine
  • Romania
  • Netherlands
  • Belgium
  • Sweden
  • Czech Republic
  • Greece
  • Portugal
  • Hungary
  • Austria
  • Switzerland
  • Serbia
  • Bulgaria
  • Denmark
  • Slovakia
  • Finland
  • Norway
  • Ireland
  • Croatia
  • Slovenia
  • Malta
• Middle East and Africa 
  • Saudi Arabia
  • UAE
  • Algeria
  • Iran
  • Turkey